Finnish Medical Foundation awarded €150,000 to CBT´s affiliated group leader Sami Ventelä
Ventelä explores new methods for diagnosing and treating head and neck cancers that form the sixth most common group of cancers globally.
– By means of the Finnish Medical Foundation grant, we will be able to study the molecular biology of head and neck cancers in more detail and in this way find prophetic biomarkers that can hopefully be used to improve the treatment results of our cancer patients in future. With the grant, we will also be able to carry out research collaboration better nationally, internationally, and locally. Together with the newly reported funding from the Cancer Society of Finland, the grant further strengthens the international-level cluster of cancer expertise of Turku Centre for Biotechnology, says Ventelä.
In total, the Finnish Medical Foundation awarded grants to 208 researchers this year. A total of 30 grants were awarded to researchers from Turku.
Yliopiston uutinen aiheesta 16.11.2018 (in Finnish only)
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026